Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

7

Portfolio Exits

3

About Crown Venture Fund

Crown Venture Fund is the venture capital arm of the Crown family of Chicago.

Crown Venture Fund Headquarter Location

Chicago, Illinois,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Crown Venture Fund News

Lyra Health Closes $75M Series C Financing Round

Mar 11, 2020

Lyra Health , a Burlingame, Calif.-based provider of innovative mental health benefits for employers, raised $75m in Series C financing. The round was led by IVP, joined by new investor Meritech Capital Partners, as well as existing investors Casdin Capital, Crown Venture Fund, Glynn Capital, Greylock Partners, Providence Ventures, Tenaya Capital, and Venrock. The company will use this funding to expand its platform technology and network of evidence-based mental health providers. Led by David Ebersman, founder and CEO, Lyra is a provider of innovative mental health benefits. Using matching technology and an innovative digital platform, Lyra connects companies and their employees–plus spouses and children–to therapists, mental health coaches, and personalized medication prescribing. The company’s platform gives access to personalized recommendations based on each individual’s needs – including therapy, coaching, and medications – and top evidence-based providers. Customers include eBay, Uber, NetApp, and Genentech. FinSMEs 11/03/2020

Crown Venture Fund Investments

7 Investments

Crown Venture Fund has made 7 investments. Their latest investment was in Lyra Health as part of their Series C on March 3, 2020.

CBI Logo

Crown Venture Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/11/2020

Series C

Lyra Health

$75M

No

18

5/7/2018

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/13/2016

Series C

Subscribe to see more

$99M

Subscribe to see more

10

9/30/2015

Series C

Subscribe to see more

$99M

Subscribe to see more

10

4/23/2014

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/11/2020

5/7/2018

4/13/2016

9/30/2015

4/23/2014

Round

Series C

Series B

Series C

Series C

Series B

Company

Lyra Health

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$75M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

18

10

10

10

10

Crown Venture Fund Portfolio Exits

3 Portfolio Exits

Crown Venture Fund has 3 portfolio exits. Their latest portfolio exit was Kala Pharmaceuticals on July 20, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/20/2017

IPO

$99M

Public

2

7/19/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/28/2013

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/20/2017

7/19/2016

5/28/2013

Exit

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.